Regen Biopharma's total assets for Q3 2025 were $196.84K, an increase of 16.14% from the previous quarter. RGBP total liabilities were $6.01M for the fiscal quarter, a 2.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.